Why is Welcure Drugs falling/rising?

As of 30-Sep, Welcure Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 5.50, which reflects a decrease of Rs. 0.26 or 4.51%. The stock has hit a new 52-week low of Rs. 5.48 today and has been on a downward trend, losing value for the past six consecutive days, resulting in a total decline of 25.88% during this period. Additionally, the stock has underperformed its sector by 4.47%. Over the past week, the stock has dropped by 21.99%, and year-to-date, it has fallen by 52.87%, contrasting sharply with the Sensex, which has gained 2.72% during the same timeframe. Despite a significant growth in net sales and positive results over the last three quarters, the stock's poor performance is compounded by its trading below all major moving averages.
In the broader market context, while the Sensex has shown resilience with a slight increase of 0.57% over the past month, Welcure Drugs has faced substantial losses, with a 43.47% decline in the same period. This stark contrast highlights the stock's struggles against the benchmark. Although the company has reported impressive growth metrics, including a 1314% increase in net sales and a 234% rise in profits over the past year, the negative sentiment surrounding the stock's recent performance and its liquidity challenges may be contributing to its current downward trajectory. The majority of shareholders being non-institutional may also indicate a lack of confidence among institutional investors, further impacting the stock's stability.